Iradimed (IRMD) Accumulated Expenses (2013 - 2026)

Iradimed (IRMD) has reported Accumulated Expenses for 14 consecutive years, with $3.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accumulated Expenses fell 4.71% year-over-year to $3.1 million in Q2 2026; TTM through Jun 2026 was $3.1 million, a 4.71% decrease from a year earlier, with the FY2025 full-year figure at $3.2 million, down 14.69% from the prior year.
• Accumulated Expenses was $3.1 million for Q2 2026 at Iradimed, up from $2.1 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $4.1 million in Q3 2025 and troughed at $1.6 million in Q1 2023.
• A 5-year average of $2.7 million and a median of $2.6 million in 2022 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses jumped 52.31% in 2022 and decreased 14.69% in 2025, its largest moves.
• Over 5 years, Accumulated Expenses stood at $2.9 million in 2022, then fell by 3.37% to $2.8 million in 2023, then jumped by 35.92% to $3.8 million in 2024, then slipped by 14.69% to $3.2 million in 2025, then dropped by 4.94% to $3.1 million in 2026.
• The last three Accumulated Expenses figures came in at $3.1 million (Q2 2026), $2.1 million (Q1 2026), and $3.2 million (Q4 2025), per Business Quant data.